Vikash Agarwal joined our Company in December 2020 as Vice President, Head of Business Development. Prior to joining Taro, Mr. Agarwal held progressively responsible roles at several renowned financial and advisory institutions, including PriceWaterhouseCoopers, Bank Muscat and HSBC UK’s Healthcare Investment Banking division, before joining Sun Pharmaceuticals as Head of Mergers and Acquisitions, where he led Sun Pharma’s acquisition of Ranbaxy. Following his relocation to the U.K., Mr. Agarwal served as Chief Corporate Development and Strategy Officer at GC Aesthetics, and most recently had an entrepreneurial stint in the health-tech space and provided business development consultative services to Taro. Mr. Agarwal earned an MBA from INSEAD, France, a Chartered Financial Analyst designation from the U.S. CFA Institute, a Chartered Accountant designation from India’s Institute of Chartered Accountants, and a Bachelor of Commerce degree from Sri Ram College in Delhi, India.